During the Two Sessions, General Secretary Xi Jinping emphasized while reviewing the Guangdong delegation's proposals: Development is the foremost priority, talent is the primary resource, and innovation is the primary driving force. If China does not pursue an innovation-driven development path, it cannot smoothly transition from old to new growth drivers and truly become strong. Strength comes from innovation, and innovation relies on talent. From the national level down to individual enterprises, talent is the foremost factor! Guided by the principles of “Science, Efficiency, and Innovation,” DiQi Pharmaceuticals Co., Ltd is committed to building a high-caliber talent system. We collaborate with universities to pioneer new models for joint talent cultivation, developing and manufacturing more affordable, high-quality, effective, long-acting, and highly compliant medicines for the public!

On the morning of September 27, 2020, the plaque presentation ceremony for the Guangdong Provincial Joint Graduate Training Demonstration Base co-established by South China University of Technology and Guangzhou DiQi Pharmaceuticals Co., Ltd. was held at DiQi Pharmaceuticals Co., Ltd. A delegation of seven professors led by Xu Yong, Vice Dean of the Graduate School at South China University of Technology, attended the ceremony on behalf of the university. The ceremony was presided over by Zhang Ling, Executive Vice President of DiQi Pharmaceuticals Co., Ltd, with attendance from all deputy managers and above at DiQi Pharmaceuticals Co., Ltd.

This accreditation will undoubtedly serve as a powerful catalyst for advancing pharmaceutical education in our province. We also hope that through the platform of this graduate training base, and with the joint efforts of both parties, we can leverage complementary strengths and forge a powerful alliance to make new and greater contributions to the development of the nation's pharmaceutical industry!